NewcelX Ltd.
What this means
- Net loss in 2025Net loss of $8.3M for the year (2024: −$7.2M).
- Private capital raiseOn Nov 18, 2026 the company filed Form D: $2.9M offered · $2.9M sold · Biotechnology. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.
What to do next
- What is a Form D? How to read a private raise noticeguide
- NT 10-K: what a late-filing notice actually meansguide
- How to check a US company before you sign a contractguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Net income (loss) | −$8.3M | −$7.2M |
| Total assets | $11.4M | $903K |
| Total liabilities | $4.2M | $8.9M |
| Stockholders’ equity | $7.3M | −$8M |
| Cash and equivalents | $2.2M | $650K |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- NewcelX Ltd.
Formerly: NLS Pharmaceutics Ltd. - CIK
- 0001783036
- Tickers
- NCEL
- Kind of filer
- Foreign private issuer
Non-accelerated filer; Emerging growth company - Legal form
- Other
- Status
- Filing with the SEC
- State of incorporation
- Switzerland
- Business address
- Zurich (outside the US)
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 20-F for the period ended Dec 31, 2025
- Last quarterly report
- —
- Latest exempt offering
- $2.9M offered · $2.9M sold
Revenue range stated: Decline to Disclose - Bankruptcy reported
- Not in our data
- Last edition event
- Nov 18, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form D · items 06B · filed Nov 18, 2026 · filing · edition of Nov 18, 2026
- Form D · items 06b · filed Aug 24, 2026 · filing
- Form D · items 06b · filed May 13, 2026 · filing
- Form SCHEDULE 13D · filed May 4, 2026 · filing
- Form 20-F · filed Apr 29, 2026 · filing
- Form SCHEDULE 13D · filed Nov 14, 2025 · filing
- Form SCHEDULE 13D · filed Nov 13, 2025 · filing
- Form F-1 · filed Sep 25, 2025 · filing
- Form D · items 06b · filed Jul 10, 2025 · filing
- Form SCHEDULE 13D · filed Jun 24, 2025 · filing
- Form 20-F · filed May 16, 2025 · filing
- Form NT 20-F · filed May 1, 2025 · filing
- Form D · items 06b · filed Apr 14, 2025 · filing
- Form D · items 06b · filed Jan 22, 2025 · filing
- Form D · items 06b · filed Oct 21, 2024 · filing
- Form F-1 · filed Aug 27, 2024 · filing
- Form D · items 06b · filed Jul 15, 2024 · filing
- Form F-1 · filed May 30, 2024 · filing
- Form 20-F · filed May 15, 2024 · filing
- Form NT 20-F · filed Apr 30, 2024 · filing
- Form D · items 06b · filed Apr 3, 2024 · filing
- Form 20-F · filed May 5, 2023 · filing
- Form NT 20-F · filed May 1, 2023 · filing